fbpx

Cambrex: Ensuring Resilience As Priorities Shift In Supply Chain Management

Virtual

PharmaLedger is participating in the roundtable discussion: Ensuring Resilience As Priorities Shift In Supply Chain Management

The COVID-19 pandemic placed significant pressure on life sciences supply chains. Lockdowns, border closures and remote working posed new challenges for pharma companies and distribution of their products. This led to pharma companies having to reconsider their supply chain strategies and networks to ensure their resilience.

This virtual roundtable will consider how life sciences companies reacted to ensure supplies of critical medicines were maintained in challenging circumstances, and how the crisis is driving lasting change in the industry to manage future risks.

PharmaLedger Presence

PharmaLedger Industry Lead Daniel Fritz (Novartis) will participate in the discussion, which will cover:
· Managing elements of the supply chain internally vs. outsourcing
· The potential benefits of dual-sourcing key ingredients
· The future of supply chains –with blockchain and strategic collaboration

Contact

Sign up for our monthly newsletter to stay up to date on all our information, news and activities in just one email a month! Unsubscribe at any time.

Subscribe!

Sign up for our monthly newsletter to stay up to date on all our information, news and activities in just one email a month! Unsubscribe at any time.